Health and Healthcare

Amgen : AMGN

All Amgen Articles

707 Articles

Jon C. Ogg | Jan 29, 2019 at 3:01 PM EST

Reality Check: Big Biotech and Big Pharma Are Becoming Identical

There is great opportunity in healthcare. There is also quite a lot of risk. Politicians and consumers alike want lower…

Chris Lange | Jan 28, 2019 at 8:30 AM EST

Short Sellers Back Off Major Biotechs

The January 15 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Jan 11, 2019 at 8:25 AM EST

Major Biotechs Scare Off Short Sellers

The December 31 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Jan 3, 2019 at 1:25 PM EST

Teva and Amgen Settle Over Kidney Disease Patent Infringement

Teva Pharmaceutical shares made a handy gain on Thursday after it was announced that the firm has settled with Amgen…

Chris Lange | Dec 27, 2018 at 8:25 AM EST

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The December 14 short interest data have been compared with the previous report, and short interest moves in the selected…

Chris Lange | Dec 12, 2018 at 8:40 AM EST

Short Sellers Still Can’t Make Up Their Mind on Major Biotech Stocks

The November 30 short interest data have been compared with the previous report, and short interest moves in the selected…

Chris Lange | Nov 28, 2018 at 8:20 AM EST

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The November 15 short interest data have been compared with the previous report, and short interest moves in the selected…

Chris Lange | Nov 12, 2018 at 8:50 AM EST

Short Sellers Raise the Stakes in Major Biotechs

The October 31 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Oct 25, 2018 at 8:20 AM EDT

Short Sellers Hike Their Bets in Major Biotechs

The October 15 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Oct 10, 2018 at 8:20 AM EDT

Short Sellers Back Off Major Biotechs

The September 28 short interest data have been compared with the previous report, and short interest in most of the…

Lee Jackson | Oct 1, 2018 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Amgen, Chipotle, Lam Research, Netgear, Teva Pharmaceutical, Western Digital and More

The top analyst upgrades, downgrades and initiations seen on Monday included Amgen, Chipotle Mexican Grill, Lam Research, Netgear, Teva Pharmaceutical…

Lee Jackson | Sep 27, 2018 at 8:35 AM EDT

Merrill Lynch Loves Large Cap Biotech: 4 Top Stocks to Buy Now

Merrill Lynch recently highlighted sectors it considers a good opportunity now that are likely to outperform in the near term,…

Chris Lange | Sep 26, 2018 at 8:15 AM EDT

Major Biotechs Have Short Sellers on the Run

The September 14 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Sep 13, 2018 at 8:20 AM EDT

Short Sellers Up the Ante in Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The August 31 short interest data…

Chris Lange | Aug 27, 2018 at 7:05 AM EDT

Short Sellers Run for Cover From Major Biotechs

The August 15 short interest data have been compared with the previous report, and short interest in most of the…

1 … 14 15 16 17 18 … 48

Amgen : AMGN

All Amgen Articles

Reality Check: Big Biotech and Big Pharma Are Becoming Identical

Short Sellers Back Off Major Biotechs

Major Biotechs Scare Off Short Sellers

Teva and Amgen Settle Over Kidney Disease Patent Infringement

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Short Sellers Still Can’t Make Up Their Mind on Major Biotech Stocks

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Short Sellers Raise the Stakes in Major Biotechs

Short Sellers Hike Their Bets in Major Biotechs

Short Sellers Back Off Major Biotechs

Top Analyst Upgrades and Downgrades: Amgen, Chipotle, Lam Research, Netgear, Teva Pharmaceutical, Western Digital and More

Merrill Lynch Loves Large Cap Biotech: 4 Top Stocks to Buy Now

Major Biotechs Have Short Sellers on the Run

Short Sellers Up the Ante in Major Biotechs

Short Sellers Run for Cover From Major Biotechs

This 15-Minute Task Is All You Need to Know What Social Security Benefit to Expect

The 401(k) Vesting Cliff That Cost One Worker $74,000 Before Age 60

A Caller’s Dad Turned $22,000 Into $1 Million on a Single Stock. Now the Family Faces a $150,000 Tax Decision

This 15-Minute Task Is All You Need to Know What Social Security Benefit to Expect

The 401(k) Vesting Cliff That Cost One Worker $74,000 Before Age 60

This 15-Minute Task Is All You Need to Know What Social Security Benefit to Expect

The 401(k) Vesting Cliff That Cost One Worker $74,000 Before Age 60

Amgen : AMGN

All Amgen Articles

Reality Check: Big Biotech and Big Pharma Are Becoming Identical

Short Sellers Back Off Major Biotechs

Major Biotechs Scare Off Short Sellers

Teva and Amgen Settle Over Kidney Disease Patent Infringement

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Short Sellers Still Can’t Make Up Their Mind on Major Biotech Stocks

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Short Sellers Raise the Stakes in Major Biotechs

Short Sellers Hike Their Bets in Major Biotechs

Short Sellers Back Off Major Biotechs

Top Analyst Upgrades and Downgrades: Amgen, Chipotle, Lam Research, Netgear, Teva Pharmaceutical, Western Digital and More

Merrill Lynch Loves Large Cap Biotech: 4 Top Stocks to Buy Now

Major Biotechs Have Short Sellers on the Run

Short Sellers Up the Ante in Major Biotechs

Short Sellers Run for Cover From Major Biotechs

This 15-Minute Task Is All You Need to Know What Social Security Benefit to Expect

The 401(k) Vesting Cliff That Cost One Worker $74,000 Before Age 60

A Caller’s Dad Turned $22,000 Into $1 Million on a Single Stock. Now the Family Faces a $150,000 Tax Decision

Featured Reads

This 15-Minute Task Is All You Need to Know What Social Security Benefit to Expect

The 401(k) Vesting Cliff That Cost One Worker $74,000 Before Age 60